Research Article| Volume 135, P4-10, May 2023

Download started.


Time to intestinal clearance of carbapenemase-producing Enterobacterales in hospital patients: a longitudinal retrospective observational cohort study

Published:March 03, 2023DOI:



      Intestinal clearance of carbapenemase-producing Enterobacterales (CPE-IC) is a cornerstone to discontinue isolation precautions for CPE patients in hospitals. This study aimed to evaluate the time to spontaneous CPE-IC and identify its potential associated risk factors.


      This retrospective cohort study was carried out between January 2018 and September 2020 on all patients in a 3200-bed teaching referral hospital with confirmed CPE intestinal carriage. CPE-IC was defined as at least three consecutive CPE-negative rectal swab cultures without a subsequent positive result. A survival analysis was performed to determine the median time to CPE-IC. A multivariate Cox model was implemented to explore the factors associated with CPE-IC.


      A total of 110 patients were positives for CPE, of whom 27 (24.5%) achieved CPE-IC. Median time to CPE-IC was 698 days. Univariate analysis showed that female sex (P=0.046), multiple CPE-species in index cultures (P=0.005), Escherichia coli or Klebsiella spp. (P=0.001 and P=0.028, respectively) were significantly associated with the time to CPE-IC. Multivariate analysis highlighted that identification of E. coli carbapenemase-producing or CPEs harbouring ESBL genes in index culture extended the median time to CPE-IC, respectively (adjusted hazard ratio (aHR) = 0.13 (95% confidence interval: 0.04–0.45]; P=0.001 and aHR = 0.34 (95% confidence interval: 0.12–0.90); P=0.031).


      Intestinal decolonization of CPE can take several months to years to occur. Carbapenemase-producing E. coli are likely to play a key role in delaying intestinal decolonization, probably through horizontal gene transfer between species. Therefore, discontinuation of isolation precautions in CPE-patients should be considered with caution.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hospital Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • WHO
        Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics.
        (Available at:) ([last accessed March 2020])
        • Mo Y.
        • Hernandez-Koutoucheva A.
        • Musicha P.
        • Bertrand D.
        • Lye D.
        • Ng O.T.
        • et al.
        Duration of carbapenemase-producing Enterobacteriaceae carriage in hospital patients.
        Emerg. Infect. Dis. 2020; 26: 2182-2185
        • Bar-Yoseph H.
        • Hussein K.
        • Braun E.
        • Paul M.
        Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis.
        J. Antimicrob. Chemother. 2016; 71: 2729-2739
        • Decraene V.
        • Phan H.T.T.
        • George R.
        • Wyllie D.H.
        A large, refractory nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Escherichia coli demonstrates carbapenemase gene outbreaks involving sink sites require novel approaches to infection control.
        Antimicrob. Agents. Chemother. 2018; 62: e01689-e01718
        • Tacconelli E.
        • Cataldo M.A.
        • Dancer S.J.
        • De Angelis G.
        • Falcone M.
        • Frank U.
        • et al.
        ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients.
        Clin. Microbiol. Infect. 2014; 20: 1-55
        • Macareño-Castro J.
        • Solano-Salazar A.
        • Dong L.T.
        • Mohiuddin M.
        • Espinoza J.L.
        Fecal microbiota transplantation for carbapenem-resistant Enterobacteriaceae: a systematic review.
        J Infect. 2022; 84: 749-759
        • Feldman N.
        • Adler A.
        • Molshatzki N.
        • Navon-Venezia S.
        • Khabra E.
        • Cohen D.
        • et al.
        Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage.
        Clin. Microbiol. Infect. 2013; 19: E190-E196
        • Li Lim Y.J.
        • Park H.Y.
        • Lee J.Y.
        • Kwak S.H.
        • Kim M.N.
        • Sung H.
        • et al.
        Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE.
        Clin. Microbiol. Infect. 2018; 24 (e5–8): 1104
        • Kim Y.K.
        • Chang I.B.
        • Kim H.S.
        • Song W.
        • Lee S.S.
        Prolonged carriage of carbapenemase-producing Enterobacteriaceae: clinical risk factors and the influence of carbapenemase and organism types.
        J. Clin. Med. 2021; 10: 310
        • Zimmerman F.S.
        • Assous M.V.
        • Bdolah-Abram T.
        • Lachish T.
        • Yinnon A.M.
        • Wiener-Well Y.
        Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge.
        Am. J. Infect. Control. 2013; 41: 190-194
        • Von Elm E.
        • Altman D.G.
        • Egger M.
        • Pocock S.J.
        • Vandenbroucke J.P.
        • Strobe Initiative
        The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.
        Int. J. Surg. 2014; 12: 1495-1499
        • Cheng V.C.C.
        • Chen J.H.K.
        • So S.Y.C.
        • Wong S.C.Y.
        • Chau P.H.
        • Wong L.M.W.
        A novel risk factor associated with colonization by carbapenemase-producing Enterobacteriaceae: use of proton pump inhibitors in addition to antimicrobial treatment.
        Infect. Control. Hosp. Epidemiol. 2016; 37: 1418-1425
        • Schechner V.
        • Kotlovsky T.
        • Tarabeia J.
        • Kazma M.
        • Schwartz D.
        • Navon-Venezia S.
        • et al.
        Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter.
        Infect. Control. Hosp. Epidemiol. 2011; 32: 497-503
        • Ben-David D.
        • Masarwa S.
        • Fallach N.
        • Temkin E.
        • Solter E.
        • Carmeli Y.
        • et al.
        Israel Long-term Care Facility (LTCF) CRE Working Group. National policy for carbapenem-resistant Enterobacteriaceae (CRE) clearance and discontinuation of contact precautions for CRE carriers in post-acute care hospitals in Israel: impact on isolation-days and new acquisitions.
        Clin Infect Dis. 2021; 1:72: 829-835
        • Dickstein Y.
        • Solter E.
        • Schwartz D.
        • Nutman A.
        • Harevrich I.
        • Wulffhart L.
        • et al.
        The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study.
        Clin Microbiol Infect. 2021; 27 (1518.e1–3)
        • Bevan E.B.
        • Jones A.M.
        • Hawkey P.M.
        Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype.
        J Antimicrob Chemother. 2017; 72: 2145-2155
        • Rodríguez-Beltrán J.
        • DelaFuente J.
        • León-Sampedro R.
        • MacLean R.C.
        • San Millán Á
        Beyond horizontal gene transfer: the role of plasmids in bacterial evolution.
        Nat Rev Microbiol. 2021; 19: 347-359
        • Göttig S.
        • Gruber T.M.
        • Stecher B.
        • Wichelhaus T.A.
        • Kempf V.A.
        In vivo horizontal gene transfer of the carbapenemase OXA-48 during a nosocomial outbreak.
        Clin Infect Dis. 2015; 15;60: 1808-1815
        • Cremet L.
        • Bourigault C.
        • Lepelletier D.
        • Guillouzouic A.
        • Juvin M.E.
        • Reynaud A.
        • et al.
        Nosocomial outbreak of carbapenem resistant Enterobacter cloacae highlighting the interspecies transferability of the bla OXA-48 gene in the gut flora.
        J Antimicrob Chemother. 2012; 67: 1041-1043
        • Lambrecht E.
        • Van Coillie E.
        • Van Meervenne E.
        • Boon N.
        • Heyndrickx M.
        • Van de Wiele T.
        Commensal E. coli rapidly transfer antibiotic resistance genes to human intestinal microbiota in the Mucosal Simulator of the Human Intestinal Microbial Ecosystem (M-SHIME).
        Int J Food Microbiol. 2019. 2; 311108357
        • Hamprecht A.
        • Sommer J.
        • Willmann M.
        • Brender C.
        • Stelzer Y.
        • Krause F.F.
        • et al.
        Pathogenicity of clinical OXA-48 isolates and impact of the OXA-48 IncL plasmid on virulence and bacterial fitness.
        Front Microbiol. 2019; 1;10: 2509
        • Knudsen P.K.
        • Gammelsrud K.W.
        • Alfsnes K.
        • Steinbakk M.
        • Abrahamsen T.G.
        • Müller F.
        • et al.
        Transfer of a bla CTX-M-1-carrying plasmid between different Escherichia coli strains within the human gut explored by whole genome sequencing analyses.
        Sci Rep. 2018; 10;8: 280